• Jan 05 2021

    NJ Recreational Cannabis Licensing: The Road Ahead 01.05.2021New Jersey Law Journal (reprinted with permission)
    On Dec. 17, 2020, the New Jersey State Assembly and the Senate passed the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (known as S21), which establishes the legal framework for New Jersey to develop, regulate and enforce the recreational cannabis marketplace.

  • Nov 23 2020

    NJ Gears Up to Regulate Adult Use Recreational Cannabis Market 11.23.2020New Jersey Law Journal (reprinted with permission)
    In the long road to legalization, on November 3, 2020, 67% of New Jersey voters approved the proposed amendment to the state’s Constitution to legalize a regulated adult use recreational cannabis market.

  • Oct 20 2020

    SCOTUS Confronted With Racist and Discriminatory History of Cannabis Criminalization 10.20.2020New Jersey Law Journal (reprinted with permission)
    Nine amicus briefs have been filed with the U.S. Supreme Court in support of Washington v. Barr demanding that the Controlled Substances Act be declared unconstitutional.

  • Sep 21 2020

    NJ Voters to Decide on Legalizing Adult-Use Cannabis in November Election 09.21.2020New Jersey Law Journal (reprinted with permission)
    If approved by New Jersey voters, a referendum in November will amend the state Constitution to permit the purchase and consumption of cannabis for recreational purposes, making New Jersey the twelfth state to legalize recreational cannabis.

  • Aug 17 2020

    Jake Honig Act Amendment Brings Economic Relief to Medical Marijuana Purchasers in NJ 08.17.2020New Jersey Law Journal (reprinted with permission)
    As New Jersey employees seek financial relief and expense reductions during the pandemic, the three-year plan by the State to eliminate sales tax on medicinal cannabis purchases by July 1, 2022 may offer financial relief for patients registered with the New Jersey Medicinal Marijuana Program who purchase medicinal cannabis.

  • Jul 13 2020

    Hemp Businesses in NJ Poised to Grow Tall and Strong 07.13.2020New Jersey Law Journal
    In this column published by the New Jersey Law Journal, Wilentz health and corporate law attorney Lisa Gora, Esq. and Chirali V. Patel, Esq. discuss the Hemp Farming Act, recently enacted by the New Jersey Department of Agriculture, and ways that hemp growers, producers and retailers may now capitalize on hemp-based business opportunities in New Jersey.

  • Jun 08 2020

    FTC Calls Foul on CBD and Cannabis Marketing Claims During COVID-19 Pandemic 06.08.2020New Jersey Law Journal
    In this article published in the New Jersey Law Journal, Wilentz attorneys Michael F. Schaff and Lisa Gora discuss the Federal Trade Commission enforcement actions against cannabis companies that advertise CBD products as effective in preventing or treating COVID-19 without obtaining approval from the United States Food and Drug Administration.

  • Apr 15 2020

    Organizing the Health Care Transaction 04.15.2020Wilentz attorneys Michael F. Schaff and Jason J. Krisza co-authored a chapter entitled “Organizing the Health Care Transaction” published in the American Health Law Association’s 2020 “Health Care Transactions Manual: Understanding the Consequences of the Health Care Deal.”

  • Feb 19 2020

    Opioid Prescribing: An AHLA 50 State Survey 02.19.2020American Health Lawyers Association
    Wilentz attorneys Michael F. Schaff, Lisa Gora and Jason J. Krisza co-authored “Opioid Prescribing: An AHLA 50 State Survey with Summaries and Links,” a resource published by the American Health Lawyers Association.

  • Jan 13 2020

    Suit-Within-a-Suit: Can a Jury Hear All Issues if There Was no Jury in the Underlying Case? 01.13.2020The New Jersey Law Journal
    In this article published by The New Jersey Law Journal , Wilentz attorneys Brian J. Molloy and Pierre Chwang explore the suit-within-a-suit methodology in legal malpractice cases and whether a litigant is entitled to a jury trial in the underlying action.

  • Load More